Gastritis Support Protocol

GastrointestinalModerate Evidence
5
supplements
2
Primary
3
Supporting
0
Grade A
40
Studies

Primary Stack

Core supplements with strongest evidence
10-20 billion CFU daily (Lactobacillus and Bifidobacterium strains)

May help with H. pylori eradication when combined with antibiotics

15 studies1,000 participants
75-150mg twice daily

Supports gastric mucosal healing; studied for gastritis and ulcers

8 studies400 participants

Supporting Stack

Additional supplements for enhanced results
380-760mg before meals

Supports mucosal protection without mineralocorticoid effects

6 studies300 participants
1000mcg daily if deficient

Atrophic gastritis impairs B12 absorption; monitor and supplement if needed

6 studies300 participants
500-1000mg daily

Traditional remedy with some anti-H. pylori activity

5 studies200 participants

How This Protocol Works

Simple Explanation

Gastritis is inflammation of the stomach lining. It can be acute (sudden onset) or chronic (develops gradually over time).

TYPES:

•Acute gastritis (sudden inflammation)
•Chronic gastritis (develops over time)
•H. pylori gastritis (bacterial infection - most common cause worldwide)
•Autoimmune gastritis (antibodies attack stomach cells)
•Erosive gastritis (from NSAIDs, alcohol)

COMMON CAUSES:

•H. pylori bacterial infection
•NSAIDs (aspirin, ibuprofen)
•Excessive alcohol
•Stress (severe illness, burns, surgery)
•Autoimmune conditions
•Bile reflux

SYMPTOMS:

•Upper abdominal pain or discomfort
•Nausea, vomiting
•Feeling of fullness after eating
•Bloating
•Loss of appetite
•Indigestion

MEDICAL TREATMENT:

•H. pylori: Triple or quadruple antibiotic therapy
•PPIs or H2 blockers to reduce acid
•Stop NSAIDs if contributing
•Limit alcohol
•Treat underlying causes

WHEN TO SEE A DOCTOR:

•Blood in vomit or stool
•Severe abdominal pain
•Unexplained weight loss
•Symptoms lasting more than a week

* Probiotics may help H. pylori treatment.

* Zinc-carnosine supports mucosal healing.

* Address underlying cause is essential.

Expected timeline: Acute gastritis often improves within days to weeks. Chronic gastritis takes longer. H. pylori eradication requires 10-14 day antibiotic course.

Clinical Perspective

Gastritis: Mucosal inflammation. H. pylori most common cause globally. Atrophic gastritis: loss of glandular cells; associated with B12 deficiency, increased gastric cancer risk. Autoimmune: parietal cell antibodies, intrinsic factor deficiency.

Treatment: H. pylori: triple therapy (PPI + clarithromycin + amoxicillin) or quadruple therapy. Probiotics as adjunct may improve eradication rates and reduce antibiotic side effects. Zinc-carnosine studied in Japan for mucosal protection. DGL traditional but limited evidence. Atrophic gastritis: monitor B12, screen for gastric cancer. Address underlying cause (NSAIDs, alcohol, H. pylori).

* Probiotics (B-grade): H. pylori adjunct. Meta-analysis: (PMID: 24045160). 10-20B CFU daily.

* Zinc-Carnosine (B-grade): Mucosal healing. Review: (PMID: 17308970). 75-150mg BID.

* DGL (C-grade): Mucosal protection. Review: (PMID: 22747745). 380-760mg before meals.

* Vitamin B12 (B-grade): Atrophic gastritis. Review: (PMID: 22566526). 1000mcg daily if deficient.

* Mastic Gum (C-grade): Anti-H. pylori. Systematic review: (PMID: 20625626). 500-1000mg daily.

Protocol notes: H. pylori testing: urea breath test, stool antigen, or biopsy. Eradication: confirm with post-treatment testing. Resistance: clarithromycin resistance increasing; culture/sensitivity if failure. PPIs: cornerstone of acid suppression; duration varies. NSAIDs: if must use, add PPI; consider COX-2 selective. Atrophic gastritis: B12 monitoring; endoscopic surveillance for dysplasia/cancer. Alcohol: abstinence or reduction. Diet: no specific diet proven; avoid individual trigger foods.